Impact-report-2020-HWO-620x400

Humanitarian Aid Program Impact Report 2020 released

The WFH Humanitarian Aid Program was developed to address the issue of access to care by working with national member organizations (NMOs) and hemophilia treatment centres (HTCs) to provide continued access to treatment for emergency situations, acute bleeds, corrective surgeries, and prophylaxis for young children.

Also available in: Français Español

The WFH Humanitarian Aid Program was developed to address the issue of access to care by working with national member organizations (NMOs) and hemophilia treatment centres (HTCs) to provide continued access to treatment for emergency situations, acute bleeds, corrective surgeries, and prophylaxis for young children. Making that level of care possible for people affected by a bleeding disorder in developing countries is an urgent and important public health challenge—and one that was magnified in 2020 due to the COVID-19 pandemic. Today, the WFH is releasing the Humanitarian Aid Program Impact Report 2020—a document which shows how the Program supported bleeding disorders communities everywhere last year.

Here are some key performance indicators (KPIs) which show the impact the Program is having in the lives of patients and their families around the world.

In 2020, the WFH Humanitarian Aid Program quickly responded to the COVID-19 pandemic by bringing education online and by collaborating with local organizations facing logistical restrictions in order to ensure that care would not be interrupted. 2020 also saw the WFH deliver the very first shipments of emicizumab to patients—a new prophylactic treatment to reduce the frequency of bleeding episodes in adults and children of all ages with hemophilia A, with and without factor VIII inhibitors. Last year, over 146 million IUs of factor were provided to patients in developing countries, despite the major logistical challenges created by the COVID-19 pandemic, such as reduced shipment traffic and closed borders.

To read the full WFH Humanitarian Aid Program Impact Report 2020, please click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and our Contributors, CSL Behring and Takeda.  To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.